The global uterine manipulator devices market was valued at USD 372 million in 2025. The market is projected to grow from USD 401 million in 2026 to USD 705 million by 2034, exhibiting a compound annual growth rate of 7.31% during the forecast period. Contrive Datum Insights presents this information in its report titled "Uterine Manipulator Devices Market Size, Share & Industry Analysis, By Product type (Disposable Uterine Manipulators, Reusable Uterine Manipulators, Robotic-Compatible Uterine Manipulators), Application (Hysterectomy, Myomectomy, Diagnostic and Other Gynecological Procedures), End user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), Surgical approach (Laparoscopic, Robotic-Assisted, Open/Conventional), Distribution channel (Direct/Institutional Tenders, Distributors), and Regional Forecast, 2026-2034".
A uterine manipulator is a surgical instrument inserted transvaginally during laparoscopic, robotic-assisted or open gynecologic procedures to reposition, stabilize and delineate the uterus so the operating surgeon can visualize tissue planes and complete dissection safely. Devices range from simple manual instruments to articulating, single-use systems with interchangeable tips and colpotomy cups, and are used chiefly during hysterectomy, myomectomy and diagnostic laparoscopy. Buyers are hospitals, ambulatory surgical centers and specialty gynecology clinics that purchase directly or through surgical-instrument distributors as part of their laparoscopic and robotic surgery instrument sets.
Rising adoption of minimally invasive and robotic-assisted gynecologic surgery
Rising adoption of minimally invasive and robotic-assisted gynecologic surgery is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.31% a year, the product type lines exposed to it move fastest: Robotic-Compatible Uterine Manipulators compounds at 13.59%, taking its share of revenue from 15% to 26% and its value from USD 55.8 million to USD 183.3 million.
On the upside, the study's bull case assumes the bull case assumes robotic-assisted gynecologic surgery programs expand faster than currently installed, pulling robotic-compatible manipulator adoption and average selling prices up across all five regions ahead of the base forecast, which would take 2034 revenue to USD 803.7 million against the USD 705 million base case.
The downside is specific. The bear case assumes reimbursement tightening and slower robotic-platform installation delay the shift away from reusable manipulators, holding disposable and robotic-compatible adoption below the base forecast through 2034, and 2034 revenue lands at USD 606.3 million. Disposable Uterine Manipulators is the drag, 52% of the 2025 base compounding at 6.79% while the market runs at 7.31%.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Hysterectomy | 68% · USD 252.96 million | Myomectomy 9.04% |
| End user | Hospitals | 58% · USD 215.76 million | Ambulatory Surgical Centers 9.43% |
| Surgical approach | Laparoscopic | 55% · USD 204.6 million | Robotic-Assisted 11.8% |
| Distribution channel | Direct/Institutional Tenders | 62% · USD 230.64 million | — |
- Based on regional analysis, North America led the global uterine manipulator devices market in 2025 with 42% of global revenue at USD 156.24 million, reaching USD 267.9 million by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 22% in 2025 to 27% in 2034, with revenue growing from USD 81.84 million to USD 190.35 million.
- Middle East and Africa remains the smallest region throughout, at 4% of 2025 revenue and 4% by 2034.
- By product type, the largest line in 2025 was Disposable Uterine Manipulators, at 52% of revenue and USD 193.44 million.
- Robotic-Compatible Uterine Manipulators is projected to grow at 13.59% over the forecast period, the fastest of any product type line.
- The United States is the largest single country market at USD 128.12 million in 2025, 34.44% of global revenue.
The report segments the market across five axes; by product type, and by application, end user, surgical approach and distribution channel; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 606.3 million and USD 803.7 million by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.